维普中文期刊产品整合服务
86篇 您的检索式:作者名="ASKLING J"
    题名 作者 年代 出处 被引量
1Characteristics of Hodgkin's lymphoma after infectious mononucleosis显示文摘Hjalgrim H Askling J Rostgaard K 2003N Engl J Med2003,349,14:1
2Autoimmune and chronic inflammatory disorders and risk of non- Hodgkin lymphoma by subtype 显示文摘Smedby KE Hjalgrim H Askling J 2006J Natl Cancer Inst2006,98,1:1
3Cancer incidence in a populationbased cohort of patients with Wegener's granulomatosis显示文摘Knight A Askling J Ekbom A 2002Int J Cancer2002,100,1:1
4The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations:a nationwide register study显示文摘Exarchou S Lindstrom U Askling J 2015Arthritis Res Ther2015,17,1:1
5Prevention of ankle sprains显示文摘TROP H ASKLING C GILLQUIST J 2000Am J Sports Med2000,,13:1
6Characteristics of hodgkin's lymphoma after infectious mono- nucleosis显示文摘HJALGRIM H ASKLING J ROSTGAARD K 2003N Engl J Med2003,349,14:1
7Association of chronic inflmnmation, not its treatment, with increased lymphoma risk in rheumatoid arthritis显示文摘Baecklund E Iliadou A Askling J 2006Arthritis Rheum2006,54,3:1
8Cancer risk in patients with rheumatoid treated with anti-turner necrosis factor alpha therapies: Does the risk change with the time since start of treatment? 显示文摘ASKLING J VAN VRF GRANATH F 2009Arthritis Rheum2009,60,11:1
9Risk for malignant lymphoma in ankylosing spondylitis:a nationwide Swedish casecontrol study显示文摘Askling J Klareskog L Blomqvist P 2006Ann Rheum Dis2006,65,11:1
10Risk for malignant lym-phoma in ankylosing spondylitis:a nationwide Swedis hcasecontrol study显示文摘Askling J Klareskog L Blomqvist P 2006Ann Rheum Dis2006,65,:1
11Urinary bladder cancer in Wegener's granulomatosis: Risks and relation to cyclophosphamide 显示文摘Knight A Askling J Granath F 2004Ann Rheum Dis2004,63,10:1
12Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics 显示文摘Smedby KE Baecklund E Askling J 2006Cancer Epidemiol Biomarkers Prey2006,15,1:1
13Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype 显示文摘Smedby KE Hjalgrim H Askling J 2006J Natl Cancer Inst2006,98,1:1
14Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with thetime since start of treatment? 显示文摘Askling J van Vollenhoven RF Granath F 2009Arthritis Rheum2009,60,:1
15Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden显示文摘Neovius M Simard JF Askling J 2011Annals of the Rheumatic Diseases2011,70,4:1
16Precention of ankle sprains显示文摘Trop H Askling C Gillquist J 2000Am J Sport Med2000,13,:1
17Decreased survival of subjects with elevated liver function tests during a 28-year follow-up显示文摘Soderberg C Stal P Askling J 2010Hepatology2010,51,2:1
18Risk and case characteristice of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden显示文摘Askling J Fored CM Brandt L 0,,07:1
19Malignant lympho-mas in autoimmunity and inflammation : a review of risks,risk factors, and lymphoma characteristics 显示文摘Smedby K E Baecklund E Askling J 2006Cancer Ep-idemiol Biomarkers Prev2006,15,1:1
20Prevention of ankle sprains显示文摘Tropp H Askling C Gillquist J 1985Am J Sports Med1985,13,:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费